Capozide

(redirected from Par Pharmaceutical)
Also found in: Wikipedia.

Capozide

A brand name for HYDROCHLOROTHIAZIDE formulated with the ANGIOTENSIN CONVERTING ENZYME inhibitor drug CAPTOPRIL.
References in periodicals archive ?
Endo's subsidiaries, Par Pharmaceutical and Par Sterile Products have obtained a preliminary injunction preventing QuVa Pharma from marketing and releasing its planned vasopressin product that would compete with Par's Vasostrict, the first and only vasopressin injection, USP, product approved by the FDA.
The company said the Megestrol Acetate Oral Suspension is the generic version of MegaceES by Strativa Pharmaceuticals, a division of Par Pharmaceutical Inc.
The launch is the fruit of a licensing partnership between Glenmark and Par Pharmaceutical, an operating company of Endo International PLC.
Endo International and Par Pharmaceutical have entered into a definitive agreement under which Endo will acquire Par for $8.
It is gratifying to see these efforts recognized by a leader in the pharmaceutical market such as Par Pharmaceutical.
Pronova BioPharma is also involved in lawsuits with Israeli generic drug maker Teva Pharmaceutical Industries (TLV: TEVA) and PAR Pharmaceutical, the generic drug division of US Par Pharmaceutical Companies Inc (NYSE: PRX), related to infringement of the company's Lovaza patents.
Par Pharmaceutical, the company's generic drug division, is the authorized generic for all strengths of AstraZeneca's Toprol XL[R].
Included in the carnage was Par Pharmaceutical Cos.
Par Pharmaceutical, Roxane, Ranbaxy Pharmaceuticals, Apotex Inc.
Strativa Pharmaceuticals (Woodcliff Lake, NJ), the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc.
In June 2007, Immtech entered into an exclusive licensing agreement with Par Pharmaceutical Companies, Inc.